Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Biosoftware to Make Elucidator Compatible With Waters' Mass Specs

NEW YORK (GenomeWeb News) — Waters and Rosetta Biosoftware plan to develop interfaces that will make Rosetta's software compatible with two of Waters' mass spectrometers, the companies said today.
 
Terms of the deal call for the companies to make Rosetta Biosoftware's Elucidator software for protein expression data management work with Waters' Q-Tof Premier and Synapt high-definition mass spectrometers.
 
The resulting compatibility will allow Waters customers to "take advantage of our mass spec technologies to comprehensively analyze the results of their most demanding experiments," said Tim Riley, vice president and managing director of Waters’ pharmaceutical business, in a statement.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.